| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 41.7× | −1.7× | |
| Price / Book | 27.5× | 2.0× | |
| Price / Sales | 10.3× | 3.9× | |
| Price / Free cash flow | 41.9× | −1.6× | |
| EV / EBITDA | 30.7× | −1.2× | |
| Earnings yield | 2.4% | −14.6% | |
| Free cash flow yield | 2.4% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,252.00 | −0.40% | $1.18T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $254.31 | −0.49% | $612.86B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $284.57 | −0.30% | $502.87B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $404.84 | +0.85% | $363.38B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.29 | −1.14% | $355.99B | 19.7× | 34.7% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.56 | −0.04% | $278.52B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $164.78 | −0.38% | $255.56B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $680.52 | −1.37% | $251.62B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $428.84 | −0.84% | $231.84B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $154.73 | −0.93% | $191.86B | 22.8× | 37.5% | +32.0% |
